Astrix Laboratories Ltd. (Amalgamated) - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Astrix Laborator

M-Cap below 100cr DeciZen not available

Astrix Laboratories Ltd. (Amalgamated) stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Astrix Laborator:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % 2.4%8%8%13.3%18.1%11.9%5.7%2.2%-0.9%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 42.7227301380507473438561362362
Sales YoY Gr.-430.8%32.8%26.2%33.4%-6.7%-7.5%28.2%-35.5%-
Adj EPS 8.92938.376131.19141.716.5-7.70
YoY Gr.-223.9%32.1%98.6%72.5%-30.6%-54.2%-60.4%-146.9%-
BVPS (₹) 377.1408.1447.4506.3637.9728.8770.4786.47650
Adj Net
Profit
4.113.117.334.459.341.218.97.5-3.50
Cash Flow from Ops. 3.8-60.211.310-2112515.4-1.88.1-
Debt/CF from Ops. 0-1.16.48-5.300-2.60.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-1%-8.5%-35.5%
Adj EPS NA-163.3%-144%-146.9%
BVPSNA8.6%1.6%-2.7%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity %
2.47.48.915.922.913.35.62.1-10
Op. Profit
Mgn %
21.816.71518.420.915.49.94.92.6NAN
Net Profit
Mgn %
9.55.85.89.111.78.74.31.3-10
Debt to
Equity
00.40.40.40.40000-
Working Cap
Days
01701922032072442522243520
Cash Conv.
Cycle
0611221231401691681382270

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Astrix Laboratories Ltd. (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 362 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 342 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 48.8

Management X-Ray of Astrix Laborator:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Astrix Laborator

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Sales42.71226.72301.15379.93506.80473.01437.79561.11361.86
Operating Expenses 33.39188.76256.13320.98401.09400.30394.48534.09361.45
Manufacturing Costs4.2126.9346.6250.2656.3718.6720.2528.6440.04
Material Costs26.96150.82194.48245.11326.69333.58330.44449.28284.29
Employee Cost 1.105.418.499.2712.049.2811.5313.6516.14
Other Costs 1.125.616.5516.345.9938.7732.2642.5120.98
Operating Profit 9.3237.9645.0158.95105.7172.7243.3027.020.41
Operating Profit Margin (%) 21.8%16.7%14.9%15.5%20.9%15.4%9.9%4.8%0.1%
Other Income 0.322.272.032.676.957.511.411.210.93
Interest 0.015.375.306.167.013.500.820.580.24
Depreciation 3.4313.5814.1514.9015.3315.7716.5816.7217.20
Exceptional Items 000000000
Profit Before Tax 6.2021.2827.6040.5690.3360.9627.3010.93-16.11
Tax 2.107.299.8013.8930.7419.848.453.70-6.44
Profit After Tax 4.111417.8026.6759.6041.1218.867.23-9.67
PAT Margin (%) 9.6%6.2%5.9%7.0%11.8%8.7%4.3%1.3%-2.7%
Adjusted EPS (₹)9.130.939.358.9131.790.941.716.0-21.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund 170.65184.65202.45229.12288.72329.84348.70355.92346.26
Share Capital 4.534.534.534.534.534.534.534.534.53
Reserves 166.13180.13197.92224.60284.19325.31344.17351.40341.73
Minority Interest000000000
Debt065.0672.0380.21110.764.2804.762.17
Long Term Debt065.0672.0380.21110.760000
Short Term Debt000004.2804.762.17
Trade Payables68.9831.7939.6667.2762.1875.5766.80126.0165.57
Others Liabilities 2.9413.3418.3323.8423.9229.3024.2620.5214.07
Total Liabilities 242.57294.84332.47400.45485.57438.99439.76507.22428.07

Fixed Assets

Gross Block162.49168.94184.38192.13200.48211.55218.44220.61231.30
Accumulated Depreciation3.4317.0131.1245.9761.1776.3892.78109.26129.05
Net Fixed Assets159.06151.93153.25146.16139.31135.18125.66111.35102.24
CWIP 2.531.500.340.910.201.340.423.170.28
Investments 4.0600000000
Inventories36.7374.0479.9498.38128.2196.0397.04116.9684.31
Trade Receivables33.6350.4178.66131.42208.77189.09194.22245.31212.44
Cash Equivalents 1.310.010.043.410.210.053.270.110.09
Others Assets5.2516.9520.2420.178.8817.2919.1530.3228.71
Total Assets 242.57294.84332.47400.45485.57438.99439.76507.22428.07

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity 3.75-60.2311.339.99-21.04124.5915.41-1.828.07
PBT 4.111417.8026.6790.3360.9627.3010.93-16.11
Adjustment 6.0127.9727.8635.4720.2619.5217.5117.6018.29
Changes in Working Capital -6.09-99.96-31.75-43.93-102.5166.78-19.18-14.7111.76
Tax Paid -0.27-2.23-2.57-8.22-29.12-22.67-10.23-15.64-5.86
Cash Flow From Investing Activity -168.99-1.36-13.75-8.54-7.86-14.55-6.95-5.52-5.27
Capex -164.95-5.45-14.05-8.55-7.87-14.55-6.95-5.52-5.27
Net Investments -4.064.060000000
Others 0.020.030.300.0100000
Cash Flow From Financing Activity 166.5560.292.451.9225.70-110.20-5.234.18-2.83
Net Proceeds from Shares 166.5500000000
Net Proceeds from Borrowing 000000000
Interest Paid 0-4.77-4.95-4.56-6.43-3.76-0.96-0.58-0.24
Dividend Paid 000000000
Others 065.067.396.4832.13-106.44-4.284.76-2.59
Net Cash Flow 1.31-1.300.033.37-3.20-0.163.23-3.16-0.03
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)2.417.889.1912.3623.0213.35.562.05-2.75
ROCE (%)3.6412.6812.5516.0127.4617.578.243.25-4.48
Asset Turnover Ratio0.180.870.971.051.181.051.011.210.8
PAT to CFO Conversion(x)0.91-4.30.640.37-0.353.030.82-0.25N/A
Working Capital Days
Receivable Days283667799118150157140224
Inventory Days3098792847984796899
Payable Days934122678072757978123

Astrix Laboratories Ltd. (Amalgamated) Stock News

Astrix Laboratories Ltd. (Amalgamated) FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Astrix Laborator on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Astrix Laborator stood at ₹0.00.
The latest P/E ratio of Astrix Laborator as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Astrix Laborator as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Astrix Laborator is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Astrix Laborator is ₹361.9 ( Cr.) .

About Astrix Laboratories Ltd. (Amalgamated)

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.